0000899243-21-042938.txt : 20211103 0000899243-21-042938.hdr.sgml : 20211103 20211103211809 ACCESSION NUMBER: 0000899243-21-042938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU JEAN I CENTRAL INDEX KEY: 0001241357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 211377653 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-01 0 0001060736 Seagen Inc. SGEN 0001241357 LIU JEAN I 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 GC/EVP, Leg Afairs Common Stock 2021-11-01 4 M 0 34876 35.95 A 103967 D Common Stock 2021-11-01 4 S 0 2080 173.00 D 101887 D Common Stock 2021-11-01 4 S 0 2588 174.20 D 99299 D Common Stock 2021-11-01 4 S 0 753 175.08 D 98546 D Common Stock 2021-11-01 4 S 0 8776 177.29 D 89770 D Common Stock 2021-11-01 4 S 0 14457 178.07 D 75313 D Common Stock 2021-11-01 4 S 0 6222 179.14 D 69091 D Non-Qualified Stock Option (right to buy) 35.95 2021-11-01 4 M 0 34876 0.00 D 2024-10-01 Common Stock 34876 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 13, 2020. Reflects sales of common stock executed in multiple transactions at prices ranging from $172.50 to $173.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $173.59 to $174.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $174.71 to $175.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $176.72 to $177.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $177.72 to $178.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $178.80 to $179.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options vested at a rate of 25% on 11/17/15 and monthly thereafter until all options were fully vested on 11/17/18. By: /s/ Jennifer Prosba For: Jean I. Liu 2021-11-03